Treatment of headache in the elderly

Current Treatment Options in Neurology

Volumn 15, Issue 1, 2013, Pages 56-62

  Hershey, Linda A ^a   Bednarczyk, Edward M ^b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Cluster; Divalproex; Elderly; Headache; Hydroxyzine; Hypnic; Lithium; Magnesium; Medication overuse; Metoclopramide; Metoprolol; Migraine accompaniment; Naproxen; Propranolol; Sleep apnea; Subarachnoid hemorrhage; Temporal arteritis; Tension; Thunderclap; Topiramate; Treatment; Trigeminal neuralgia

Indexed keywords

ACETAZOLAMIDE; ACETYLSALICYLIC ACID; AMITRIPTYLINE; CAFFEINE; DOXEPIN; HYDROXYZINE; INDOMETACIN; KETOROLAC; LAMOTRIGINE; LITHIUM; LYSINE ACETYLSALICYLATE; MAGNESIUM; METOCLOPRAMIDE; METOPROLOL; NAPROXEN; PLACEBO; PROPRANOLOL; SUMATRIPTAN; TOPIRAMATE; VALPROATE SEMISODIUM; VALPROIC ACID;

ANOREXIA; ARTICLE; BARIATRIC SURGERY; COUGH HEADACHE; DIARRHEA; DIZZINESS; DROWSINESS; DRUG CONTRAINDICATION; DRUG MECHANISM; EXERCISE; FATIGUE; GERIATRICS; HEADACHE; HEART ARRHYTHMIA; HUMAN; HYPNIC HEADACHE; HYPOTENSION; IMPOTENCE; LIVER FAILURE; MENTAL DISEASE; MIGRAINE; MORBID OBESITY; NAUSEA; NEPHROLITHIASIS; PANCREATITIS; PARESTHESIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESTLESSNESS; SEDATION; SIDE EFFECT; SOMNOLENCE; STOMACH PAIN; TENSION HEADACHE; WEAKNESS; WEIGHT GAIN; WEIGHT REDUCTION; WHEEZING;

EID: 84873088608     PISSN: 10928480     EISSN: 15343138     Source Type: Journal    
DOI: 10.1007/s11940-012-0205-6     Document Type: Article

References (39)

1. Prencipe M, Casini AR, Ferretti C, et al. Prevalence of headache in an elderly population: attack frequency, disability, and use of medication. J Neurol Neurosurg Psychiatry. 2001;70:377-81.
2. Lipton R, Stewart W, Diamond S, et al. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache. 2001;41:646-57.
3. Pascual J, Berciano J. Experience in the diagnosis of headaches that start in elderly people. J Neurol Neurosurg Psychiatry. 1994;57:1255-7.
4. Qureshi A, Mendelow A, Hanley D. Intracerebral hemorrhage. Lancet. 2009;373:1632-44.
5. Johnson K, Ziemba A, Garb J. Improvement in headaches with continuous positive airway pressure for obstructive sleep apnea. Headache. 2012 (Epub ahead of print).
6. Castillo J, Munoz P, Guitera V, Pascual J. Epidemiology of chronic daily headache in the general population. Headache. 1999;39:190-6.
7. Lipton R, Bigal M, Steiner T, Silberstein S, Olesen J. Classification of the primary headaches. Neurology. 2004;63:427-35.
8. Toth C. Medications and substances as a cause of headache: a systematic review of the literature. Clin Neuropharmacol. 2003;26:122-36.
9. Ferrari A. Headache: one of the most common and troublesome adverse reactions to drugs. Curr Drug Saf. 2006;1:43-58.
10. Fisher C. Late-life migraine accompaniments as a cause of unexplained transient ischemic attacks. Can J Neurol Sci. 1980;7:9-17.
11. Young W. A knock-out punch: C. Miller Fisher's migraine accompaniments. Headache. 2008;48:726-7.
12. Ramadan N, Levine S, Welch K. Cerebral blood flow in migraine accompaniments and vertebrobasilar ischemia. Stroke. 1994;25:1219-22.
13. Fisher C. The posterior cerebral artery syndrome. Can J Neurol Sci. 1986;13:232-9.
14. Ferbert A, Bruckmann H, Drummen R. Clinical features of proven basilar artery occlusion. Stroke. 1990;21:1135-42.
15. Dodick D. Thunderclap headache. J Neurol Neurosurg Psychiatry. 2002;72:6-11.
16. Pascual J, Iglesias F, Oterino A, Vasquez-Barquero A, Berciano J. Cough, exertional, and sexual headaches: an analysis of 72 benign and symptomatic cases. Neurology. 1996;46:1520-4.
17. Russell M. Epidemiology and genetics of cluster headaches. Lancet Neurol. 2004;3:279-83.
18. Lisotto C, Mainardi F, Maggioni F, Zanchin G. Episodic hypnic headache? Cephalalgia. 2004;24:681-5.
19. Lipton R, Lowenkopf T, Bajwa Z, et al. Cardiac cephalgia: a treatable form of exertional headache. Neurology. 1997;49:813-6.
20. Grace A, Horgan J, Breathnach K, et al. Anginal headache and its basis. Cephalalgia. 1997;17:195-6.
21. Lance J, Lambros J. Unilateral exertional headache as a symptom of cardiac ischemia. Headache. 1998;38:315-6.
22. Papademetriou V. Cardiovascular risk assessment and triptans. Headache. 2004;44 Suppl 1:S31-9.
23. Yu S, Yang X, Zhao G, et al. Body mass index and migraine: a survey of the Chinese adult population. J Headache Pain. 2012 (Epub ahead of print).
24. Novack V, Fuchs L, Lantsberg L, et al. Changes in headache frequency in premenopausal obese women with migraine after bariatric surgery: a case series. Cephalalgia. 2011;31:1336-42.
25. Bond D, Vithiananthan S, Nash J, et al. Improvement of migraine headaches in severely obese patients after bariatric surgery. Neurology. 2011;76:1135-8.
26. Varkey E, Cider A, Carlsson J, Linde M. Exercise as migraine prophylaxis: a randomized study using relaxation and topiramate as controls. Cephalalgia. 2011;31:1428-38.
27. Cete Y, Dora B, Ertan C, Ozdemir C, Oktay C. A randomized prospective placebo-controlled study of intravenous magnesium sulfate vs metoclopramide in the management of acute migraine attacks in the emergency department. Cephalalgia. 2005;25:199-204.
28. Tek D, McClellan D, Olshaker J, Allen C, Arthur D. A prospective, double-blind study of metoclopramide hydrochloride for the control of migraine in the emergency department. Ann Emerg Med. 1990;19:1083-7.
29. Friedman B, Corbo J, Lipton R. A trial of metoclopramide vs sumatriptan for the emergency department treatment of migraines. Neurology. 2005;64:463-8.
30. Klapper J, Stanton J. Ketorolac versus DHE and metoclopramide in the treatment of migraine headaches. Headache. 1991;31:523-4.
31. Leninger T, Pageler L, Stude P, Diener H, Limmroth V. Comparison of intravenous valproate with intravenous lysine-acetylsalisylic acid in acute migraine attacks. Headache. 2005;45:42-6.
32. Freitag F, Collins S, Carlson H, et al. A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis. Neurology. 2002;58:1652-9.
33. Silberstein S, Collins S. Safety of divalproex sodium in migraine prophylaxis: an open-label, long-term study: long-term safety of Depakote in Headache Prophylaxis Study Group. Headache. 1999;39:633-43.
34. Silberstein S, Holland S, Freitag F, et al. Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults. Neurology. 2012;78:1337-45.
35. Gupta P, Singh S, Goyal V, Shukla G, Behari M. Low-dose topiramate versus lamotrigine in migraine prophylaxis (the Lotolamp study). Headache. 2007;47:402-12.
36. Ashtari F, Shaygannejad V, Akbari M. A double-blind, randomized trial of low-dose topiramate vs propranolol in migraine prophylaxis. Acta Neurol Scand. 2008;118:301-5.
37. Shaygannejad V, Janghorbani M, Ghorbani A, et al. Comparison of the effect of topiramate and sodium valproate in migraine prevention: a randomized blinded crossover study. Headache. 2006;46:642-8.
38. Diener H, Hartung E, Chrubasik J, et al. A comparative study of oral acetylsalicylic acid and metoprolol for the prophylactic treatment of migraine: a randomized, controlled, double-blind, parallel-group phase- III study. Cephalalgia. 2001;21:120-8.
39. Rao B, Das D, Taraknath V, Sarma Y. A double-blind controlled study of propranolol and cyproheptadine in migraine prophylaxis. Neurol India. 2000;48:223-6.